Related Experiment Video
Updated: Jun 13, 2026
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Henoch-Schönlein purpura
1Division of Immunology and Rheumatology, Department of Pediatrics, University of Virginia Health System, Charlottesville, Virginia, USA. fts@virginia.edu
Current Opinion in Rheumatology
|May 18, 2010
Summary
Recent advances in Henoch-Schönlein purpura (HSP) research clarify genetic factors and pathogenesis but leave treatment, especially for nephritis, uncertain. Further trials are needed to establish optimal therapies for this condition.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Genetics
Background:
- Henoch-Schönlein purpura (HSP) is a common vasculitis affecting small blood vessels.
- Understanding its genetic basis and disease mechanisms is crucial for effective management.
Purpose of the Study:
- To review recent advancements in the genetic susceptibility, pathogenesis, and treatment of Henoch-Schönlein purpura.
- To identify current knowledge gaps and future research directions.
Main Methods:
- Literature review of recent studies on HSP genetics, pathogenesis, and therapeutic interventions.
- Analysis of findings from retrospective reports and clinical observations.
Main Results:
- Progress has been made in understanding HSP's genetic susceptibility and pathogenesis, though significant gaps remain.
- Corticosteroids alleviate pain in HSP but do not prevent or alter the course of nephritis.
- Optimal treatment for severe HSP nephritis is still undetermined, despite various drug investigations.
Conclusions:
- Knowledge regarding HSP's genetic susceptibility, pathogenesis, and treatment is incomplete.
- Further research is required to elucidate the genetic and pathogenic factors of HSP.
- Multicenter clinical trials are essential to determine the most effective treatments for HSP, particularly severe nephritis.
Related Concept Videos
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:25Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
01:30Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
01:25Peptic Ulcer Disease I: Introduction
Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...